RT @1daysooner: Dr. Alexander Douglas and Dr. Adrian Hill -- Immunological considerations for SARS-CoV-2 human challenge studies, "The risk…
RT @1daysooner: Dr. Alexander Douglas and Dr. Adrian Hill -- Immunological considerations for SARS-CoV-2 human challenge studies, "The risk…
RT @1daysooner: Dr. Alexander Douglas and Dr. Adrian Hill -- Immunological considerations for SARS-CoV-2 human challenge studies, "The risk…
Dr. Alexander Douglas and Dr. Adrian Hill -- Immunological considerations for SARS-CoV-2 human challenge studies, "The risk to volunteers should be substantially lower than the risk associated with infection in an age-matched community cohort." #COVID19 ht
Interesting piece... should we do challenge studies? #COVID-19 https://t.co/UGWQp1zUIA
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
Very interesting read and thoughts to consider
@DeanAguila sorry alam ko work-related pero kasi I think a US company is considering human challenge trials. :-)
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: See new Comment article from Alexander Douglas & Adrian Hill @JennerInstitute on SARS-CoV-2 human challenge studies http…
Immunological considerations for SARS-CoV-2 human challenge studies | Nature Reviews Immunology https://t.co/oBsemWwCHl
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
RT @NatRevImmunol: Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
Immunological considerations for SARS-CoV-2 human challenge studies https://t.co/jHYYqlL0z3
RT @NatRevImmunol: NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by San…
See new Comment article from Alexander Douglas & Adrian Hill @JennerInstitute on SARS-CoV-2 human challenge studies https://t.co/5tbIcz1SAq #COVID19 #vaccine #immunology
NEW Comment article 'Immunological considerations for SARS-CoV-2 human challenge studies' https://t.co/YKwHAHILHk by Sandy Douglas and Adrian Hill @JennerInstitute @NDMOxford @UniofOxford https://t.co/J1oS1hiik8